Last reviewed · How we verify
Cenobomate Oral Suspension Fasted — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Cenobomate Oral Suspension Fasted (Cenobomate Oral Suspension Fasted) — SK Life Science, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cenobomate Oral Suspension Fasted TARGET | Cenobomate Oral Suspension Fasted | SK Life Science, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cenobomate Oral Suspension Fasted CI watch — RSS
- Cenobomate Oral Suspension Fasted CI watch — Atom
- Cenobomate Oral Suspension Fasted CI watch — JSON
- Cenobomate Oral Suspension Fasted alone — RSS
Cite this brief
Drug Landscape (2026). Cenobomate Oral Suspension Fasted — Competitive Intelligence Brief. https://druglandscape.com/ci/cenobomate-oral-suspension-fasted. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab